Eliezer Huberman
Impact in
- Cancer Research top 0.5%
- Carcinogens and Genotoxicity Assessment
- Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Biochemical and Molecular Research 31
- DNA Repair Mechanisms 17
- Retinoids in leukemia and cellular processes 16
- Glycosylation and Glycoproteins Research 8
-
- Carcinogens and Genotoxicity Assessment 35
- Co-authors
- Leo Sachs (20 shared papers)F. Collart (28 shared papers)Michael F. Callaham (11 shared papers)David A. Glesne (14 shared papers)Charles Heidelberger (9 shared papers)Andreas I. Constantinou (5 shared papers)Kaoru Kiguchi (10 shared papers)Robert Langenbach (7 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (20 papers)Journal of Biological Chemistry (9 papers)International Journal of Cancer (9 papers)Carcinogenesis (8 papers)Cancer Letters (4 papers)
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
Eliezer Huberman
153 papers receiving 8.5k citations
Eliezer Huberman's Hit Papers
Peers
Comparison fields: 5 of 139
- Cancer Research 2.5k
- Pharmacology 798
- Molecular Biology 5.8k
- Biochemistry 500
- Oncology 1.5k
Countries citing papers authored by Eliezer Huberman
This map shows the geographic impact of Eliezer Huberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eliezer Huberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eliezer Huberman more than expected).
Fields of papers citing papers by Eliezer Huberman
This network shows the impact of papers produced by Eliezer Huberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eliezer Huberman. The network helps show where Eliezer Huberman may publish in the future.
Co-authors
The 25 scholars most cited alongside Eliezer Huberman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 155 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. | 1994 | 462 |
| 2 | Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents. Hit paper breakdown → | 1979 | 451 |
| 3 | Identification of mutagenic metabolites of benzo(a)pyrene in mammalian cells. Hit paper breakdown → | 1976 | 398 |
| 4 | 2003 | 386 | |
| 5 | 1987 | 279 | |
| 6 | 1981 | 255 | |
| 7 | Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. | 1990 | 199 |
| 8 | 1974 | 194 | |
| 9 | 1986 | 187 | |
| 10 | 1971 | 155 | |
| 11 | Stimulation of differentiated functions in human melanoma cells by tumor-promoting agents and dimethyl sulfoxide. | 1979 | 154 |
| 12 | 1995 | 153 | |
| 13 | 1999 | 145 | |
| 14 | 1971 | 143 | |
| 15 | 1988 | 140 | |
| 16 | 1971 | 138 | |
| 17 | 1981 | 132 | |
| 18 | Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate. | 1983 | 132 |
| 19 | 1987 | 130 | |
| 20 | Malignant transformation of cells derived from mouse prostate by epoxides and other derivatives of polycyclic hydrocarbons. | 1972 | 130 |
About Eliezer Huberman
Eliezer Huberman is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Health, Toxicology and Mutagenesis and Oncology, having authored 155 papers that have together received 9.3k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (35 papers), Biochemical and Molecular Research (31 papers), DNA Repair Mechanisms (17 papers), Retinoids in leukemia and cellular processes (16 papers), Cytomegalovirus and herpesvirus research (13 papers), HIV/AIDS drug development and treatment (11 papers), Effects and risks of endocrine disrupting chemicals (9 papers) and Glycosylation and Glycoproteins Research (8 papers). The work is most often cited by research in Cancer Research (2.5k citations), Pharmacology (798 citations), Molecular Biology (5.8k citations), Biochemistry (500 citations) and Oncology (1.5k citations). Eliezer Huberman has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Leo Sachs, F. Collart, Michael F. Callaham, David A. Glesne, Charles Heidelberger, Andreas I. Constantinou, Kaoru Kiguchi, Robert Langenbach, Yong Zhao and James K. Selkirk. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry, International Journal of Cancer, Carcinogenesis and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.